comparemela.com

Latest Breaking News On - Indian pharma market - Page 1 : comparemela.com

Ajanta Pharma Buyback: Should Investors Tender Their Shares?

Ajanta Pharma Buyback: Should Investors Tender Their Shares?
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

India
Ajanta-pharma
Linkedin
Facebook
National-list-of-essential-medicines
Twitter
National-list
Essential-medicines
Trade-generics
Indian-pharma-market

India Inc's earnings growth reverts to mean in the fourth quarter

Sai Prabhakar Yadavalli - bl. research bureau analyzes India Inc's Q4 performance and outlook for FY25.

India
China
Chinese
Twitter
Facebook
Linkedin
India-inc
Indian-pharma-market

Indian pharma market posts robust 9.5% growth in March

India s pharmaceutical market saw a 9.5% growth in March, reaching 16,158 crore in sales. The Moving Annual Total reached 197,976 crore with a 6.5% growth rate, with cardiology and anti-infectives among the top performers.

India
New-delhi
Delhi
Sheetal-sapale
Moving-annual-total
Indian-pharma-market
Pharmarack
Uipm
Pharmatrac

Sun Pharma scouting for innovative therapies to boost India business

Approved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, almost five times more than the narrow time window of 4-5 hours offered by current treatment options like tissue plasminogen activator (TPA) called thrombolytic drugs that dissolve the clots that cause strokes. An ischemic stroke is a medical emergency that occurs when blood supply to part of a brain is blocked or reduced.

Business-news
Breaking-newsbudget
Latest-news-updates
Economic-times
Economic-times-news-app
Daily-market-updates
Live-business
Sun-pharma
Innovative-therapies
India-business
Drugmaker

Indian pharma market grows over 9 per cent in December

Among the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last month, according to data from research firm PharmaTrac. Antibiotic drug Augmentin and anti-diabetes Glycomet GP continued to be the top-selling medicine brands.

Sheetal-sapale
Indian-pharma-market
Augmentin
Pharmatrac
Glycomet-gp
Mankind-pharma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.